SCHEMBL326717

SCHEMBL326717

Oc1ccc(-c2ccccc2)cc1I

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 1/20 0.64
ESR2 Q92731 4/20 0.57
KDM4E B2RXH2 2/20 0.57
MEN1 O00255 2/20 0.57
KMT2A Q03164 2/20 0.57
USP2 O75604 1/20 0.57
ALDH1A1 P00352 1/20 0.57
LMNA P02545 1/20 0.57
HSP90AA1 P07900 1/20 0.57
GAA P10253 1/20 0.57
MAPT P10636 1/20 0.57
HPGD P15428 1/20 0.57
ALOX15 P16050 1/20 0.57
ALOX12 P18054 1/20 0.57
HTT P42858 1/20 0.57
HSD17B10 Q99714 1/20 0.57
ACMSD Q8TDX5 3/20 0.53
HNF4A P41235 2/20 0.53
DHFR P00374 1/20 0.53
MCL1 Q07820 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19880348 0.88 APP (0.55) ALOX5ESR2KDM4EMEN1KMT2A
SCHEMBL13590994 0.84 ALOX5 (0.62) ALOX5ESR2MEN1KMT2AAPP
SCHEMBL5412429 0.82 ALOX5 (0.64) ALOX5ESR2KDM4EMEN1KMT2A
SCHEMBL8994752 0.79 SNCA (0.47) ALOX5MEN1KMT2ALMNAALOX15
SCHEMBL5493701 0.78 APP (0.41) ALOX5ESR2KDM4EMEN1KMT2A
SCHEMBL928289 0.78 ALOX5 (1.00) ALOX5ESR2KDM4EMEN1KMT2A
SCHEMBL29848221 0.78 ALOX5 (1.00) ALOX5ESR2KDM4EMEN1KMT2A
SCHEMBL10391765 0.78 ALDH1A1 (0.47) ALOX5ESR2KDM4EMEN1KMT2A
SCHEMBL27642244 0.78 HPGD (0.52) ALOX5ESR2KDM4EMEN1KMT2A
SCHEMBL24434313 0.76 ALOX5 (0.70) ALOX5ESR2KDM4EMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 70 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1330679-A Plastic moulding materials which can be detected by x-ray contrast BAYER AG (DE) 2002-01-09 CN claimed
EP-1155073-A1 PLASTIC MOULDING MATERIALS WHICH CAN BE DETECTED BY X-RAY CONTRAST Bayer Aktiengesellschaft (DE) 2001-11-21 EP claimed
WO-2000036002-A1 PLASTIC MOULDING MATERIALS WHICH CAN BE DETECTED BY X-RAY CONTRAST BAYER AKTIENGESELLSCHAFT (DE) 2000-06-22 WO claimed
US-20240027902-A1 CHEMICALLY AMPLIFIED RESIST COMPOSITION AND PATTERNING PROCESS SHIN-ETSU CHEMICAL CO., LTD. (JP) 2024-01-25 US disclosed
US-20240027902-A1 CHEMICALLY AMPLIFIED RESIST COMPOSITION AND PATTERNING PROCESS SHIN-ETSU CHEMICAL CO., LTD. (JP) 2024-01-25 US disclosed
US-11835860-B2 Resist composition and patterning process SHIN-ETSU CHEMICAL CO., LTD. (JP) 2023-12-05 US disclosed
US-11835860-B2 Resist composition and patterning process SHIN-ETSU CHEMICAL CO., LTD. (JP) 2023-12-05 US disclosed
US-20230359119-A1 RESIST COMPOSITION AND PATTERN FORMING PROCESS SHIN-ETSU CHEMICAL CO., LTD. (JP) 2023-11-09 US disclosed
US-20230305394-A1 RESIST COMPOSITION AND PATTERN FORMING PROCESS SHIN-ETSU CHEMICAL CO., LTD. (JP) 2023-09-28 US disclosed
US-20230305394-A1 RESIST COMPOSITION AND PATTERN FORMING PROCESS SHIN-ETSU CHEMICAL CO., LTD. (JP) 2023-09-28 US disclosed
US-20230305393-A1 RESIST COMPOSITION AND PATTERN FORMING PROCESS SHIN-ETSU CHEMICAL CO., LTD. (JP) 2023-09-28 US disclosed
CN-1418187-A Carboxylic acid derivatives as IP antagonists HOFFMANN LA ROCHE (CH) 2003-05-14 CN disclosed
US-6509406-B1 X-ray contrastable plastic materials comprising 0.1 wt. % to 25 wt. % of 4,4'-diiodobiphenyl. BAYER AKTIENGESELLSCHAFT (DE) 2003-01-21 US disclosed
EP-1265853-A1 CARBOXYLIC ACID DERIVATIVES AS IP ANTAGONISTS F. Hoffmann-La Roche AG (CH) 2002-12-18 EP disclosed
EP-1193250-A1 PHENYL SULFAMATE DERIVATIVES Teikoku Hormone Mfg. Co., Ltd. (JP) 2002-04-03 EP disclosed
CN-1330679-A Plastic moulding materials which can be detected by x-ray contrast BAYER AG (DE) 2002-01-09 CN disclosed
US-20010056100-A1 Carboxylic acid derivatives as IP antagonists SYNTEX (U.S.A.) LLC 2001-12-27 US disclosed
EP-1155073-A1 PLASTIC MOULDING MATERIALS WHICH CAN BE DETECTED BY X-RAY CONTRAST Bayer Aktiengesellschaft (DE) 2001-11-21 EP disclosed
WO-2001068591-A1 CARBOXYLIC ACID DERIVATIVES AS IP ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2001-09-20 WO disclosed
WO-2000036002-A1 PLASTIC MOULDING MATERIALS WHICH CAN BE DETECTED BY X-RAY CONTRAST BAYER AKTIENGESELLSCHAFT (DE) 2000-06-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010056100-A1 Carboxylic acid derivatives as IP antagonists GABRP, GPBAR1, FFAR1 ALOX5 1031/4885ESR2 803/4885KDM4E 4538/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.